Dronabinol

Dronabinol: antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns

Study provides rigorous data to support clinical evaluation of THC as a low-toxic therapy option in acute leukemia patients. In related work, full-spectrum, natural derivatives of cannabis may work more effectively than their pharmaceutical counterparts.

View this review (yellow link) or download:

This paper is also stored here:    http://bit.ly/2KVVXnD     inside the CED Foundation Archive

To explore related information, click the keywords below:

Benjamin Caplan, MDDronabinol: antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns
read more

A 2018 study finds that cannabis can alleviate symptoms of medications used for chronic pain as well as serve as an alternative treatment for seizures, pain, and inflammation.

Benjamin Caplan, MDA 2018 study finds that cannabis can alleviate symptoms of medications used for chronic pain as well as serve as an alternative treatment for seizures, pain, and inflammation.
read more

Dronabinol May Provide Relief for Sleep Apnea Patients

Medical Cannabis and the Treatment of Obstructive Sleep Apnea: An American Academy of Sleep Medicine Position Statement

Obstructive sleep apnea is a sleep disorder causing episodic airway obstruction that results in the brief “apneic” (cessation of breathing) episodes for brief periods of time. A recent study investigating Dronabinol, a synthetic cannabis derivative, as a potential therapy for sleep apnea resulted in an improvement of 32% in the apnea-hypopnea index. However, the American Academy of Sleep Medicine does not endorse medical cannabis as a treatment for sleep apnea, due to what they point to as a lack of knowledge surrounding the long-term effects of its use. ” Based on these results, cannabis and its components should be further researched to determine its potential for sleep apnea treatment.

This paper is also stored here: http://bit.ly/2YZDTN3 inside the CED Foundation Archive

Benjamin Caplan, MDDronabinol May Provide Relief for Sleep Apnea Patients
read more

Dronabinol use in a patient with Bipolar Disorder

Dronabinol-Induced Hypomania: A Case Report and Literature Review

An HIV patient who also suffers from bipolar disorder was administered dronabinol, a synthetic cannabis alternative. Following a dosage increase, the previously stable patient presented to his psychiatrist in a state of hypomania. Although this singular case study cannot be used to make any definitive conclusion, it underscores the need for further research surrounding the effects of cannabis on mood

http://bit.ly/2W275Bb

Benjamin Caplan, MDDronabinol use in a patient with Bipolar Disorder
read more